🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubbee Onkoloo Interstishiyali › Kansas

Qorannoo klinikaalii Dhukkubbee Onkoloo Interstishiyali Kansas keessatti

Qorannoo 13 Dhukkubbee Onkoloo Interstishiyali f Kansas keessatti hirmaatuu jiru.

Magaalota Kansas keessatti

Takkalaa qorannoo (Ingiliffa)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA002, Kansas City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07179380

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Kansas City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

  • University of Kansas School of Medicine, Kansas City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06328777

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • The University of Kansas Medical Center Research Institute, Kansas City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT05943535

Interstitial Lung Disease Research Unit Biobank

  • The University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT05392881

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

  • University of Kansas Medical Center, Kansas City
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT04624490

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

  • University of Kansas, Kansas City
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 03-Cam-2024 · NCT06397677

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.